Larry McMillan Stock Market Update Video 10/14/2024
By Lawrence G. McMillan
Join Larry McMillan as he discusses the current state of the stock market on October 14, 2024.
Join Larry McMillan as he discusses the current state of the stock market on October 14, 2024.
Danaher: Operational Excellence Meets Cyclical Pause – A Hold Amid Recovery Prospects Source link
SRPT Sarepta Therapeutics $160.72 +37.22 (+30.14%) (As of 05:50 PM ET) 52-Week Range $55.25 ▼ $173.25 P/E Ratio 1,461.09 Price Target $177.65 Sarepta Therapeutics NASDAQ: SRPT is leading the game in precision genetic medicine and biotechnology. Sarepta Therapeutics’ stock price has witnessed a surge of over 40% after receiving expanded FDA approval for its Duchenne muscular…
Source: Investor Presentation of Hindustan Unilever Ltd Source link
Vienna Insurance Group AG (OTCPK:VNRFY) Q3 2024 Earnings Conference Call November 26, 2024 9:00 AM ET Company Participants Nina Higatzberger – Head of Investor RelationsLiane Hirner – CFOPeter Hofinger – Deputy CEO Conference Call Participants August Marcan – UBSThomas Unger – Erste GroupBhavin Rathod – HSBC Operator Ladies and gentlemen, welcome to the VIG Update…
President Trump’s approach to trade negotiations has been marked by an emphasis on “strategic uncertainty.” This means he deliberately creates ambiguity, which his team believes works to their advantage. Trump has repeatedly stated that the US doesn’t necessarily have to sign any trade agreements. In fact, he claims the country could sign up to 25…
by Calculated Risk on 3/24/2025 11:18:00 AM Today, in the CalculatedRisk Real Estate Newsletter: Policy and 2025 Housing Outlook Excerpt: I started the year taking Fed Chair Jerome Powell’s approach to the impact of policy: I’d wait to see what was implemented before changing my outlook. Now we know a little more. Although there is…